ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 23 07:09 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 19 07:08 ET
ProQR Therapeutics | 20-F: Registration statement / Annual report / Transition report
Mar 13 08:48 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 13 07:13 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 15 07:52 ET
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Van Herk Investments B.V.(10.1%),Van Herk Investments THI B.V.(10.1%), etc.
Feb 14 06:13 ET
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Van Herk Investments B.V.(8.8%),Van Herk Investments THI B.V.(8.8%), etc.
Feb 9 06:39 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 19 00:00 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 5 00:00 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 8, 2023 07:37 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 7, 2023 10:00 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 27, 2023 07:06 ET
ProQR Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Van Herk Investments B.V.(5.3%),Van Herk Investments THI B.V.(5.3%), etc.
Sep 14, 2023 17:20 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Aug 3, 2023 07:15 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aug 1, 2023 07:15 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
May 17, 2023 16:05 ET
ProQR Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
May 16, 2023 07:15 ET
ProQR Therapeutics | EFFECT: Others
Apr 25, 2023 00:15 ET
ProQR Therapeutics | 424B5: Prospectus
Apr 24, 2023 16:30 ET
ProQR Therapeutics | CORRESP: CORRESP
Apr 20, 2023 16:09 ET
No Data
No Data